Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC.CSBR · Entity 7013 | Director | November 05, 2025 | November 07, 2025 |
| DAVITA INC.DVA · Entity 3482 | CFO and Treasurer | May 07, 2026 | May 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHAMPIONS ONCOLOGY, INC.
Report date November 05, 2025 · Filed November 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.80 · Expires 2035-11-05 | Direct | 21,216 |
Reported balance
After 2025-11-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-05 · Grant · Acquired 21,216 · Balance 21,216 F1: The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively.
DAVITA INC.
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 132,434 |
Reported balance
After 2026-05-07 transaction · row 1
1 source rowRow 1 · 2026-05-07 · Sale · Disposed 51,471 · Balance 132,434 F1: Represents the weighted average sale price of $192.099. The range of prices for the sale of these shares was $191.510 - $192.765 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the weighted average sale price of $192.099. The range of prices for the sale of these shares was $191.510 - $192.765 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
KINDRED HEALTHCARE, INC
Report date July 02, 2018 · Filed July 02, 2018
Section 16 reporting ended · disclosed 2018-07-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-07-02 transaction · row 1
1 source rowRow 1 · 2018-07-02 · Disposition to issuer · Disposed 75,167 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 04, 2019 Filed Nov 6, 2019 22:14 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 16,667 | $5.43 Strike: $5.43 | $90,501.81 |
DisclosureSEC source: 0001628280-19-013528 · wf-form4_157307845404785.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Common Stock · 16,667 shares Expires 2024-11-03 F1 · derivative.exercise_date: The Options vest and are exercisable over a twelve month period, with vesting to occur on November 4, 2019, February 4, 2020, May 4, 2020 and August 4, 2020, respectively. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 22:45 UTC | DAVITA INC. DVA · Entity 3482 | GrantStock Appreciation Rights · Derivative | 110,000 | $0.00 Strike: $52.41 | $0.00 |
DisclosureSEC source: 0000927066-19-000118 · wf-form4_156115709852634.xml · derivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2024-06-20 F3 · derivative.exercise_date: The stock appreciation rights are scheduled to vest 50% on each of June 20, 2022 and June 20, 2023, respectively, subject to the terms and conditions of the applicable award agreement. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 22:45 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 6,014 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-19-000118 · wf-form4_156115709852634.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,717 F2 · shares: Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 11,301 shares as described in footnote 1 above. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 22:45 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 22,601 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-19-000118 · wf-form4_156115709852634.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,731 F1 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 28, 2018, in which 11,301 shares vested on June 19, 2019, and the remaining 11,300 vest on December 19, 2020. Read SEC document |
| May 15, 2019 Filed May 17, 2019 23:32 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 29,869 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-19-000088 · wf-form4_155813591292881.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,130 F1 · shares: These restricted stock units are scheduled to vest 50% each on 5/15/2022 and 5/15/2023, subject to continued service through each applicable vesting date. F2 · balance_after: Includes 11,261 restricted stock units, which may be settled solely in shares of common stock, that the Reporting Person had previously reported on Table II. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 20:01 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionWarrant to purchase shares of Common Stock · Derivative | 4,167 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001628280-19-000100 · wf-form4_154663204408380.xml · derivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,494,956 Underlying: Common Stock · 4,167 shares Expires 2019-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 20:01 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 4,167 | $4.80 | $20,001.60 |
DisclosureSEC source: 0001628280-19-000100 · wf-form4_154663204408380.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,113,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2018 Filed Nov 5, 2018 16:41 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 16,667 | $12.73 Strike: $12.73 | $212,170.91 |
DisclosureSEC source: 0001628280-18-013557 · wf-form4_154143607370813.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Common Stock · 16,667 shares Expires 2023-11-01 F1 · derivative.exercise_date: The Options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2018, February 1, 2019, May 1, 2019 and August 1, 2019, respectively. Read SEC document |
| October 12, 2018 Filed Oct 12, 2018 18:45 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionOption to purchase Common Stock · Derivative | 100,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001628280-18-012512 · wf-form4_153936992313751.xml · derivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2025-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options were immediately exercisable upon grant on July 21, 2016. Read SEC document |
| October 12, 2018 Filed Oct 12, 2018 18:45 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Tax withholdingCommon Stock | 12,021 | $17.47 | $210,006.87 |
DisclosureSEC source: 0001628280-18-012512 · wf-form4_153936992313751.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,109,710 F1 · kind: Represents a "net exercise" of outstanding stock options. These shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on September 30, 2018. F1 · price: Represents a "net exercise" of outstanding stock options. These shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on September 30, 2018. Read SEC document |
| October 12, 2018 Filed Oct 12, 2018 18:45 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 100,000 | $2.10 | $210,000.00 |
DisclosureSEC source: 0001628280-18-012512 · wf-form4_153936992313751.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,121,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 14:22 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | SaleCommon Stock | 22,535 | $17.02 | $383,545.70 |
DisclosureSEC source: 0001628280-18-012240 · wf-form4_153857652991356.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,021,731 Read SEC document |
| July 02, 2018 Filed Jul 2, 2018 13:01 UTC | KINDRED HEALTHCARE, INC KND · Entity 165258 | Disposition to issuerCommon Stock | 75,167 | $9.00 | $676,503.00 |
DisclosureSEC source: 0001209191-18-040204 · doc4.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 15, 2018 Filed May 18, 2018 01:48 UTC | DAVITA INC. DVA · Entity 3482 | GrantStock Appreciation Rights · Derivative | 56,306 | $0.00 Strike: $66.29 | $0.00 |
DisclosureSEC source: 0000927066-18-000112 · wf-form4_152660808484110.xml · derivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,306 Underlying: Common Stock · 56,306 shares Expires 2023-05-15 F1 · security: 50% will vest on each of 5/15/2021 and 5/15/2022, subject to continued service through each applicable vesting date. Read SEC document |
| May 15, 2018 Filed May 18, 2018 01:48 UTC | DAVITA INC. DVA · Entity 3482 | GrantRestricted Stock Units · Derivative | 11,261 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000927066-18-000112 · wf-form4_152660808484110.xml · derivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,261 Underlying: Common Stock · 11,261 shares Expires 2023-05-15 F1 · security: 50% will vest on each of 5/15/2021 and 5/15/2022, subject to continued service through each applicable vesting date. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 21:17 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 16,667 | $3.21 Strike: $3.21 | $53,501.07 |
DisclosureSEC source: 0001628280-17-011470 · wf-form4_151060777234020.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Common Stock · 16,667 shares Expires 2022-10-31 F1 · derivative.exercise_date: The Options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 1, 2018, May 1, 2018 and August 1, 2018, respectively. Read SEC document |
| May 24, 2017 Filed May 25, 2017 12:19 UTC | KINDRED HEALTHCARE, INC KND · Entity 165258 | GrantCommon Stock | 14,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035219 · doc4.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,167 F1 · shares: These shares represent restricted stock granted to the reporting person. These shares will fully vest on 5/24/2018. Read SEC document |
| February 21, 2017 Filed Feb 24, 2017 01:45 UTC Amendment | DAVITA INC. DVA · Entity 3482 | GrantStock Appreciation Rights · Derivative | 145,159 | $0.00 Strike: $68.89 | $0.00 |
DisclosureSEC source: 0001179110-17-003098 · edgar.xml · derivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,159 Underlying: Common Stock · 145,159 shares Expires 2021-02-21 F1 · derivative.exercise_date: The Stock Appreciation Rights were granted on 2/21/2017. 50% will vest on 2/21/2020 and the remaining 50% will vest on 2/21/2021. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 22:10 UTC | DAVITA INC. DVA · Entity 3482 | GrantStock Appreciation Rights · Derivative | 145,159 | $0.00 Strike: $68.89 | $0.00 |
DisclosureSEC source: 0001179110-17-003045 · edgar.xml · derivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,159 Underlying: Common Stock · 145,159 shares Expires 2021-02-21 F1 · derivative.exercise_date: The Stock Appreciation Rights were granted on 2/21/2017. 50% will vest on 2/21/2020 and the remaining 50% will vest on 2/21/2021. Read SEC document |
| October 28, 2016 Filed Nov 1, 2016 16:08 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 279,177 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001628280-16-020509 · wf-form4_147801651403628.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,177 Underlying: Common Stock · 279,177 shares Expires 2026-10-31 F1 · derivative.exercise_date: The Options vest and are exercisable over a twelve month period, with vesting to occur on January 31, 2017, April 30, 2017, July 31, 2017 and October 31, 2017, respectively. Read SEC document |
| October 18, 2016 Filed Oct 20, 2016 15:13 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 418 | $1.70 | $710.60 |
DisclosureSEC source: 0001628280-16-020145 · wf-form4_147697638819088.xml · nonDerivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,044,266 Read SEC document |
| October 18, 2016 Filed Oct 20, 2016 15:13 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 381 | $1.69 | $643.89 |
DisclosureSEC source: 0001628280-16-020145 · wf-form4_147697638819088.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,043,848 Read SEC document |
| October 18, 2016 Filed Oct 20, 2016 15:13 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 201 | $1.69 | $340.49 |
DisclosureSEC source: 0001628280-16-020145 · wf-form4_147697638819088.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,043,467 Read SEC document |
| October 18, 2016 Filed Oct 20, 2016 15:13 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,000 | $1.70 | $1,697.70 |
DisclosureSEC source: 0001628280-16-020145 · wf-form4_147697638819088.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,043,266 Read SEC document |
| October 14, 2016 Filed Oct 14, 2016 20:40 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 300 | $1.65 | $495.00 |
DisclosureSEC source: 0001628280-16-020083 · wf-form4_147647761895317.xml · nonDerivative · entry 9 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,042,266 Read SEC document |
| October 14, 2016 Filed Oct 14, 2016 20:40 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,000 | $1.66 | $1,658.10 |
DisclosureSEC source: 0001628280-16-020083 · wf-form4_147647761895317.xml · nonDerivative · entry 8 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,041,966 Read SEC document |
| October 13, 2016 Filed Oct 14, 2016 20:40 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,000 | $1.67 | $1,670.00 |
DisclosureSEC source: 0001628280-16-020083 · wf-form4_147647761895317.xml · nonDerivative · entry 7 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,040,966 Read SEC document |
| October 13, 2016 Filed Oct 14, 2016 20:40 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,000 | $1.68 | $1,679.00 |
DisclosureSEC source: 0001628280-16-020083 · wf-form4_147647761895317.xml · nonDerivative · entry 6 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,039,966 Read SEC document |
| October 13, 2016 Filed Oct 14, 2016 20:40 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,000 | $1.68 | $1,676.60 |
DisclosureSEC source: 0001628280-16-020083 · wf-form4_147647761895317.xml · nonDerivative · entry 5 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,038,966 Read SEC document |
| October 13, 2016 Filed Oct 14, 2016 20:40 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,000 | $1.67 | $1,670.00 |
DisclosureSEC source: 0001628280-16-020083 · wf-form4_147647761895317.xml · nonDerivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,037,966 Read SEC document |
| October 13, 2016 Filed Oct 14, 2016 20:40 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,000 | $1.67 | $1,670.00 |
DisclosureSEC source: 0001628280-16-020083 · wf-form4_147647761895317.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,036,966 Read SEC document |
| October 13, 2016 Filed Oct 14, 2016 20:40 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 500 | $1.69 | $844.50 |
DisclosureSEC source: 0001628280-16-020083 · wf-form4_147647761895317.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,035,966 Read SEC document |
| October 13, 2016 Filed Oct 14, 2016 20:40 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 500 | $1.68 | $842.20 |
DisclosureSEC source: 0001628280-16-020083 · wf-form4_147647761895317.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,035,466 Read SEC document |
| October 07, 2016 Filed Oct 7, 2016 18:18 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 5,000 | $1.64 | $8,200.00 |
DisclosureSEC source: 0001628280-16-019992 · wf-form4_147586429644371.xml · nonDerivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,034,966 Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 18:18 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,500 | $1.61 | $2,421.45 |
DisclosureSEC source: 0001628280-16-019992 · wf-form4_147586429644371.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,029,966 Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 18:18 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 702 | $1.62 | $1,137.24 |
DisclosureSEC source: 0001628280-16-019992 · wf-form4_147586429644371.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,028,466 Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 18:18 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,000 | $1.61 | $1,610.80 |
DisclosureSEC source: 0001628280-16-019992 · wf-form4_147586429644371.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,027,764 Read SEC document |
| September 23, 2016 Filed Sep 26, 2016 20:24 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 33 | $1.65 | $54.45 |
DisclosureSEC source: 0001628280-16-019767 · wf-form4_147492147652839.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,026,764 Read SEC document |
| September 21, 2016 Filed Sep 21, 2016 18:26 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,000 | $1.73 | $1,728.70 |
DisclosureSEC source: 0001628280-16-019675 · wf-form4_147448239459972.xml · nonDerivative · entry 5 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,026,731 Read SEC document |
| September 21, 2016 Filed Sep 21, 2016 18:26 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,000 | $1.70 | $1,700.00 |
DisclosureSEC source: 0001628280-16-019675 · wf-form4_147448239459972.xml · nonDerivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,025,731 Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 18:26 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,000 | $1.63 | $1,627.70 |
DisclosureSEC source: 0001628280-16-019675 · wf-form4_147448239459972.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,024,731 Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 18:26 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,000 | $1.64 | $1,639.90 |
DisclosureSEC source: 0001628280-16-019675 · wf-form4_147448239459972.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,023,731 Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 18:26 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,000 | $1.63 | $1,627.40 |
DisclosureSEC source: 0001628280-16-019675 · wf-form4_147448239459972.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,022,731 Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 20:03 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 100,765 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001628280-16-019572 · wf-form4_147388339023554.xml · derivative · entry 14 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,765 shares Expires 2025-11-01 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F8 · derivative.exercise_date: Vested as to 75,574 shares on grant; remainder to vest on October 31, 2016. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 20:03 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 96,283 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019572 · wf-form4_147388339023554.xml · derivative · entry 13 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 96,283 shares Expires 2024-11-01 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F6 · derivative.exercise_date: Fully Vested. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 20:03 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 16,101 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019572 · wf-form4_147388339023554.xml · derivative · entry 12 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,101 shares Expires 2023-11-05 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F6 · derivative.exercise_date: Fully Vested. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 20:03 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 112,331 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019572 · wf-form4_147388339023554.xml · derivative · entry 11 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 112,331 shares Expires 2023-11-05 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F4 · derivative.exercise_date: Vesting to occur upon completion of performance criteria that have not been set. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 20:03 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 112,331 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019572 · wf-form4_147388339023554.xml · derivative · entry 10 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 112,331 shares Expires 2023-11-05 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F7 · derivative.exercise_date: Vested as to 84,249 shares on grant; remainder to vest on November 5, 2016. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 20:03 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 182,580 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019572 · wf-form4_147388339023554.xml · derivative · entry 9 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 182,580 shares Expires 2020-10-25 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F4 · derivative.exercise_date: Vesting to occur upon completion of performance criteria that have not been set. Read SEC document |
| July 21, 2016 Filed Sep 14, 2016 20:03 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 182,580 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019572 · wf-form4_147388339023554.xml · derivative · entry 8 ACKERMAN JOEL · CIK 0001220630 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 182,580 shares Expires 2020-10-25 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F6 · derivative.exercise_date: Fully Vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.